Clinical Trials Browser

Phase 4 × Interventional × Adenocarcinoma Of Esophagus × Clear all

NCT02366819 2025-06-13

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Phase 4 Recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT00628784 2008-07-24

Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer

Phase 4 Unknown

Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus